Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q4 2017 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.70M$1.70Mderived−2.7% vs Q4 2016 Net Income$247.77K$247.77Kderived+5.5% vs Q4 2016 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$1,459,612+3.2% Operating Incomederived-$27,761N/M Operating Cash Flowderived$271,641−35.2% Free Cash Flowderived$354,199−15.5% Margins · derivedGross margin86.0%+5.0 pt vs Q4 2016
Operating margin-1.6%−17.5 pt vs Q4 2016
Net margin14.6%+1.1 pt vs Q4 2016
ended Dec 31, 2017 · filed Mar 29, 2018 · 88 d after period end